tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

BTAI Stock Latest News

BioXcel Therapeutics names interim CCO amid IGALMI expansion
Company AnnouncementsBioXcel Therapeutics names interim CCO amid IGALMI expansion
2d ago
8K
BTAI
BioXcel Therapeutics appoints Pavao as acting CCO
PremiumThe Fly
BioXcel Therapeutics appoints Pavao as acting CCO
2d ago
BTAI
BioXcel Therapeutics planning to submit sNDA seeking FDA approval for IGALMI
PremiumThe Fly
BioXcel Therapeutics planning to submit sNDA seeking FDA approval for IGALMI
7d ago
BTAI
BioXcel Therapeutics Holds Annual Stockholders Meeting
PremiumCompany Announcements
BioXcel Therapeutics Holds Annual Stockholders Meeting
1M ago
8K
BTAI
BioXcel Therapeutics’ Igalmi supplement for new indication approved by FDA
PremiumThe Fly
BioXcel Therapeutics’ Igalmi supplement for new indication approved by FDA
2M ago
BTAI
BioXcel Therapeutics’ Q3 2025 Earnings and Clinical Updates
PremiumCompany AnnouncementsBioXcel Therapeutics’ Q3 2025 Earnings and Clinical Updates
2M ago
BTAI
BioXcel Therapeutics reports Q3 EPS ($2.18), consensus ($1.34)
Premium
The Fly
BioXcel Therapeutics reports Q3 EPS ($2.18), consensus ($1.34)
2M ago
BTAI
BTAI Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
BTAI Earnings this Week: How Will it Perform?
2M ago
BTAI
BioXcel Presents Phase 3 Study on BXCL501
PremiumCompany Announcements
BioXcel Presents Phase 3 Study on BXCL501
2M ago
8K
BTAI
BioXcel Therapeutics Updates sNDA Timeline for IGALMI®
PremiumCompany Announcements
BioXcel Therapeutics Updates sNDA Timeline for IGALMI®
3M ago
8K
BTAI
Bioxcel’s BXCL501: A Promising Study in Pediatric Mental Health
PremiumCompany Announcements
Bioxcel’s BXCL501: A Promising Study in Pediatric Mental Health
3M ago
BTAI
BioXcel Announces Positive SERENITY At Home Study Results
PremiumCompany Announcements
BioXcel Announces Positive SERENITY At Home Study Results
3M ago
8K
BTAI
BioXcel announces results from correlation study from SERENITY At-Home trial
PremiumThe FlyBioXcel announces results from correlation study from SERENITY At-Home trial
3M ago
BTAI
Bioxcel Therapeutics: Buy Rating Affirmed Amid NASDAQ Compliance and Promising IGALMI™ Outlook
Premium
Ratings
Bioxcel Therapeutics: Buy Rating Affirmed Amid NASDAQ Compliance and Promising IGALMI™ Outlook
4M ago
BTAI
BioXcel Therapeutics regains compliance with Nasdaq
Premium
The Fly
BioXcel Therapeutics regains compliance with Nasdaq
4M ago
BTAI
Bioxcel Therapeutics Files Current Report on Form 8-K
PremiumCompany Announcements
Bioxcel Therapeutics Files Current Report on Form 8-K
4M ago
8K
BTAI
BioXcel Therapeutics says has raised $37.3M since July 1 under ATM offering
PremiumThe Fly
BioXcel Therapeutics says has raised $37.3M since July 1 under ATM offering
4M ago
BTAI
BioXcel Therapeutics completes enrollment in clinical study
PremiumThe Fly
BioXcel Therapeutics completes enrollment in clinical study
4M ago
BTAI
Promising Phase 3 Trial Results and Growth Potential for Bioxcel Therapeutics’ BXCL501 Reinforce Buy Rating
PremiumRatings
Promising Phase 3 Trial Results and Growth Potential for Bioxcel Therapeutics’ BXCL501 Reinforce Buy Rating
4M ago
BTAI
BioXcel Therapeutics price target raised to $4 from $2 at Mizuho
PremiumThe FlyBioXcel Therapeutics price target raised to $4 from $2 at Mizuho
4M ago
BTAI
Sell Rating on Bioxcel Therapeutics Amid Efficacy and Strategic Concerns
Premium
Ratings
Sell Rating on Bioxcel Therapeutics Amid Efficacy and Strategic Concerns
4M ago
BTAI
BioXcel Therapeutics Reports Positive Phase 3 Trial Results
Premium
Company Announcements
BioXcel Therapeutics Reports Positive Phase 3 Trial Results
4M ago
8K
BTAI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >